Share on

Global Polymerase Chain Reaction Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – By Type, Application & Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 1987
Pages: 175
Formats: report pdf report excel report power bi report ppt

Polymerase Chain Reaction Market Size (2022 to 2027)

The size of the global polymerase chain reaction market was valued at USD 8.3 billion in 2022. It is estimated to be growing at a CAGR of 6.60% to reach USD 11.43 billion by 2027.

The polymerase chain reaction is duplicating or producing billions or millions of copies of a particular DNA/ genetic sample. This process helps scientists to collect a minute sample and produce billions of copies of genetic material. The molecular biology field utilizes this polymerase chain reaction more than any other field. These polymerase chain reaction technologies duplicate the millions of copies of a piece of deoxyribonucleic acid or any other genetic material. These technologies identify criminals and child identities in the forensics department. These devices also diagnose tuberculosis, AIDS, Lyme, and middle ear infections. Also, in biotechnology and microbiology, and the academic field, these polymerase chain reaction technologies are used to identify microorganisms and their culture and cause diseases. Polymerase chain reaction technologies are also used in genetic engineering, molecular biology, and research. For example, polymerase chain reaction technologies play a significant role in drug discovery and clinical diagnostics and help scientists in their studies. In addition, polymerase chain reaction technologies also play a significant role in DNA sequencing and cloning.


Y-O-Y growth in the geriatric population, growing prevalence of infectious diseases, and increased viral and other chronic infections with the highest spread ratio are forecasted to drive the global polymerase chain reaction market growth.

According to the Centre for Disease Control and Prevention, around 5000 deaths are remarkably noted due to influenza infection registered in the United States, according to reports as of 2015. However, even with the highest spread ratio, this rising number of infections and other diseases can be curbed by PCR techniques developments. Hence, this is an augmenting factor for market growth. In addition, an increase in polymerase chain reaction adoption for various drug developments, disease identifications, and research applications is expected to boost the global polymerase chain reaction market growth.

Growing research developments and funding activities in gene therapy and other genetics and biological fields also increase market size and revenue. Furthermore, the growing adoption of personalized medicines, personalized health check-ups, and various health benefits due to schemes are further expected to accelerate the global polymerized chain reaction market. In addition, increasing awareness and acceptance of polymerase chain reaction technologies accelerate the market's growth rate. 

Rising cases of genetic disorders to support market growth.

The continuous increase in the cases of genetically inherited diseases like thalassemia, cystic fibrosis, hemophilia, etc., has increased the demand for the market due to the use of procedures like prenatal genetic testing, which allows diagnosis and finding treatments for such problems before their advancement in the womb of the mother. The WHO estimates that 10 out of every 1000 people are affected by a genetic disorder, further promoting the importance of the market. 


The rise in non-validated tests and other fraud systems is expected to hamper the global polymerase chain reaction market.

The lack of reimbursement policies is also likely to inhibit the market growth for the polymerase chain reaction market. In addition, high costs associated with the equipment's setup, installation, and maintenance are expected to hinder the market's growth rate. 

Many skilled staff and workers are required to carry out this procedure. Hence the lack of professional staff and trained workers also negatively impacts market growth. Reduction in the number of polymerase chain reaction processes in various fields is challenging for this market. Additionally, the publication of information on PCR testing is minimal, making it difficult to understand and perform the procedure. 

Impact of covid-19 on the global polymerase chain reaction market:

The covid -19 cases have been increasing across the world. The disease's expansion through major countries has boosted demand for virus diagnostic tests in the suspicious population, mainly due to the scarcity or non-existence of rapid or specific diagnostic testing for these diseases. Furthermore, due to the significant applications of PCR in clinical diagnostics, the segment is expected to expand rapidly over the forecast period. 

In addition, the COVID-19 epidemic has accelerated the advancement of polymerase chain reaction science. As a result, several studies are being conducted to prove the PCR test's accuracy. In March 2020, for example, researchers from the Center for Advanced Measurement Science collaborated with Chongqing University and the Wuhan and Beijing Centers for Disease Control and Prevention (CDC) to test the sensitivity of dPCR kits. In addition, two further experiments in China found that sensitivity was increased compared to the gold standard RT-qPCR. Furthermore, Bio-Rad Laboratories produced a dPCR test to identify the SARS-CoV-2 virus in March 2020.






Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Type, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa.

This market research report on the global polymerase chain reaction market has been segmented and sub-segmented based on type, application, and region.

Polymerase Chain Reaction Market - By Type:

  • PCR consumables
  • PCR instruments

Based on the type, the consumables segment accounted for the largest market share of the polymerase chain reaction market in 2020 and is more likely to continue its growth throughout the forecast period. Significant demand for genetic testing and technologically sophisticated diagnostic tests in countries with unmet health needs is driving segment expansion. In addition, introducing new products will likely lead to the segment's development. For example, Biocore Co. Ltd. released the first dPCR-based NIPT kits to diagnose chromosomal anomalies in March 2018.

The PCR instruments segment is also expected to show fast progress during the forecast period due to technological advancements in polymerase chain reaction instruments. 

Polymerase Chain Reaction Market - By Application:

  • DNA fingerprinting
  • DNA sequencing
  • DNA cloning
  • gene expression

The gene expression segment dominates the market due to the application of genomics in the polymerase industry. In addition, genomes help determine the fundamental nature of several food products, helping establish their reaction to certain diseases and helping determine personalized diet treatments. Therefore, the gene expression segment is expected to grow significantly during the forecast period. 

The DNA fingerprinting segment is also expected to grow significantly during the forecast period due to the several advantages of DNA fingerprinting. The DNA fingerprint is unique to each individual and therefore is used in investigations from crime scenes with the collection of hair stands, nails, teeth, etc., which can all determine unique DNA. It is also used in court proceedings for paternity testing cases and biometrics and safety biotechnologies, thus pushing the market to grow. 

Polymerase Chain Reaction Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America represented the largest share of the worldwide PCR market in 2019, took after by Europe. These two regions are relied upon to hold their position throughout the forecast period. The North American area was among the first to support and implement PCR-based applications to diagnose irresistible sicknesses, for example, HIV. Factors such as the establishment of new biotechnologies and pharmaceuticals, equipment and reagents necessary for carrying out this process, technological advancements, research and developments, and others drive market growth for the polymerase chain reaction market in North America.

Favorable government regulatory guidelines and reimbursement programs further drive the North American market growth. The Department of Health and Human Services announced in February 2020 that the emergency use of diagnostics for COVID-19 diagnosis had been approved. The number of diagnostics products launched in the region improved due to this approval. In the regional market, the united states contributed the largest market share of polymerase chain reaction. The presence of advanced healthcare infrastructure and government initiatives are propelling market growth in the country. The Canadian polymerase chain reaction market is slightly contributing to regional market growth.

The European market is estimated to be the second-largest regional market in the global polymerase chain reaction market during the forecast period. It is likely to maintain its growth in the next five years. Growth in healthcare expenditure and technological advancements in the healthcare sector are propelling market growth in the region. The UK, Germany, France, Spain, and Italy are the major growth contributors in the region. over the years, the UK accounted for the largest market share of the polymerase chain reaction market and is forecasted to grow throughout the forecast period.

The Asia Pacific area is required to speak to the most elevated development rate during the forecast period. The Asia Pacific holds the most significant shares due to its population growth. In addition, other factors include increased chronic diseases, increased adoption of personalized medicines, awareness in early detection of diseases, and increased market value for this market in the Asia Pacific region.

Emerging countries like China, Japan, and India significantly contribute to the APAC market, and the support will likely maintain throughout the forecast period. In 2019, the Indian market witnessed a stable growth rate estimated to continue during the forecast period.

MEA region expects slow growth due to a lack of skilled staff, laboratories, and other industries, a lack of awareness of biotechnologies and drug developments, high literacy rate.


Companies leading the global polymerase chain reaction market profiled in the report are Beckman Coulter, Clontech Laboratories, Eppendorf, Fluidigm, PerkinElmer, bioMérieux, Harvard Bioscience, Maxim Biotech, Promega, and Siemens Healthcare.


In September 2022, Temasek invested $85 million in Molbio Diagnostics at a unicorn valuation. The Goa-based diagnostics chain Molbio Diagnostics Pvt. Ltd. has received an investment of $85 million (about 680 crores) from the Singaporean investment company Temasek. According to someone who knows the situation, the company will have a post-round valuation of $1.6 billion. The most recent fundraising consists of primary and secondary market transactions with angel investor partial exits.

In October 2022, Abbott received urgent FDA approval for the first commercial monkeypox test. Abbott is the first business to offer a test commercially under the EUA process. The Alinity m System from Abbott automatically completes each step required to run the test, including sample preparation and PCR assembly. Abbott created the method to speed up the testing process for infectious diseases. Abbott has out clinical evaluation research to substantiate the monkeypox test. The test's accuracy in detecting the presence of the monkeypox virus at two and four times the limit of detection was evaluated. All 36 positive samples had the virus, which Alinity m MPXV found. Additionally, the test accurately stated that the virus was absent from 35 test-negative samples.

In October 2022, Provista Diagnostics successfully launched a suite of PCR testing services, according to Todos Medical. Gerald Commissiong, CEO of Todos Medical Ltd., informs Stephen Gunnion of Proactive that the company's CLIA/CAP accredited lab Provista Diagnostics has completed a pilot launch of a polymerase chain reaction (PCR) testing services in the small Florida town of Dunnellon. According to Commissiong's statement, Proactive, non-COVID-related testing will play a more significant role in Provista's business strategy as it prepares to introduce its breast cancer blood test, Videssa, in 2023.

Please wait. . . . Your request is being processed


How big is the global PCR market?

As per our research report, the global polymerase chain reaction (PCR) market size is expected to grow to USD 11.43 billion by 2027.

Which segment by type led the global PCR market in 2021?

Based on the type, the consumables segment dominated the global PCR market in 2021.

Which region led the global PCR market in 2021?

Geographically, the North American regional market dominated the polymerase chain reaction (PCR) market in 2021.

Which are the significant players operating in the global PCR market?

Beckman Coulter, Clontech Laboratories, Eppendorf, Fluidigm, PerkinElmer, bioMérieux, Harvard Bioscience, Maxim Biotech, Promega, and Siemens Healthcare are some of the notable companies operating in the global PCR market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample